⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology

32.00USD

+0.2900 (+0.91%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on CAI.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 32.00
P/E86.0
Dvd Ind Yld0.0%
P/B15.28
P/S9.1
Curr EV/T12M EBITDA50.0
Mkt Cap (USD)9.0B
Curr EV (USD)8.7B
2)

Per Share Data

EPS T12M0.57
DPS—
Bk Val Per Sh2.09
Rev/Sh3.50
Cash/Sh2.81
Curr Shares Out282.6M
FCF/Sh0.44
3)

Cash Flow Analysis

P/CF53.6
Curr P/FCF73.0
CF/NI1.6
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales17.0%
Eff Interest Rate12.2%
4)

Growth Potential

Dil EPS 1Y Gr-51.0%
Cap 1Y Gr145.1%
BPS 1Y Gr124.5%
R&D To Sales11.8%
Retention Rate100.0%
Rev 1Y Gr97.0%
FCF 1Y Gr126.4%
Assets 1Y Gr227.5%
5)

Profitability

EBITDA0.2B
EBIT0.2B
Operating Margin15.5%
Pretax Margin10.6%
Net Margin10.6%
ROA9.6%
ROE20.1%
ROC—
Asset Turnover0.91
6)

Structure

Current Ratio5.53
Quick Ratio4.75
Debt/Assets32.0%
Debt/Com Eq66.4%
Net Debt/EBITDA-2.45
Tot Debt/Capital39.9%
Gross Margin69.8%
EBIT/Int Exp3.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.